Clinical Trials Browser

Phase 3 × Methylphenidate × 1 year × Clear all

NCT06905587 2025-12-11

EMBRAIN

Phase 3 Recruiting

Brain Neoplasms, Neoplasms

NCT03525873 2025-10-20

A Study of Cancer Related Fatigue in Patients With Metastatic Cancer Receiving Anti-PD1 Immunotherapy

Phase 3 Active not recruiting

Neoplasm Metastasis, Recurrence